Trial Profile
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs Dapansutrile (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Olatec Industries
- 27 Aug 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 07 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 05 Mar 2015 Planned End Date changed from 1 Mar 2015 to 1 Aug 2015 according to ClinicalTrials.gov record.